thrombectomy catheter
Image courtesy of
Boston Scientific
The AngioJet ZelanteDVT thrombectomy catheter has been approved for commercialization in the US and Europe.
The device received the CE mark and approval from the US Food and Drug Administration to treat deep vein thrombosis (DVT) in large-diameter
upper and lower limb peripheral veins.
The ZelanteDVT catheter was designed to remove large venous clot burdens and facilitate rapid restoration of blood flow, potentially decreasing procedural time, relieving symptoms, and reducing late complications.
The ZelanteDVT Thrombectomy Set is intended for use with the AngioJet Ultra Console to break apart and remove thrombi, including DVT, from iliofemoral and lower extremity veins greater than or equal to 6.0 mm in diameter and upper extremity peripheral veins greater than or equal to 6.0 mm in diameter.
The set is also intended for use with the AngioJet Power Pulse technique for the controlled and selective infusion of physician-specified fluids, including thrombolytic agents, into the peripheral vascular system.
The ZelanteDVT catheter is a product of Boston Scientific. For more information on the device, visit the company’s website.
